- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02295137
Image Fusion of Preprocedural CTA With Real Time Fluoroscopy to Enhance EVAR Repair
November 14, 2014 updated by: University Health Network, Toronto
Image Fusion of Pre-procedural CTA With Real-time Fluoroscopy to Guide Proper Renal and Visceral Arteries Catheterization During Advanced Endovascular Aortic Aneurysms Repair: A Feasibility Study
Abdominal Aortic Aneurysm (AAA) is a potentially life threatening condition.
If the aneurysm ruptures, the mortality can be as high as 80%.
Endovascular aneurysms repair (EVAR) is a minimal invasive procedure and has been widely used on treating AAA.
Advanced endovascular techniques are used to treat patients with more complex pathology by using custom-made devices and additional stents.
In order to accomplish the technical success on advanced EVAR, with the current imaging equipment and technique for EVAR procedures (i.e.
live x-ray fluoroscopy and 2-D digital subtraction angiography (DSA)), multiple angiograms on the target arteries (arteriograms) are required.
Subsequently patients are exposed to higher dose of contrast and radiation, compared to conventional EVAR.
This study is to assess the feasibility of proper visceral and renal arteries catheterization using a 3D model obtained from pre-procedural computed tomographic angiography (CTA), fused with real-time fluoroscopy, without contrast injection or angiographic run-offs thus minimizing the contrast use and patient radiation exposure while achieving procedure success during Advanced EVAR.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kong Teng Tan, MD
- Phone Number: 6166 416-340-4800
- Email: kongteng.tan@uhn.ca
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1C4
- Recruiting
- Toronto General Hospital
-
Contact:
- Kong Teng Tan, MD
- Phone Number: 6166 416-340-4800
- Email: kongteng.tan@uhn.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- male or female >= 18 years;
- scheduled for advanced EVAR for abdominal aortic aneurysm.
Exclusion Criteria:
- Pregnancy;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: pre-procedure image guidance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedure success
Time Frame: within 1 day
|
Evaluate the technical success of advanced EVAR by using pre-procedural CTA images as guidance
|
within 1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (ANTICIPATED)
October 1, 2015
Study Completion (ANTICIPATED)
October 1, 2015
Study Registration Dates
First Submitted
October 27, 2014
First Submitted That Met QC Criteria
November 14, 2014
First Posted (ESTIMATE)
November 20, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
November 20, 2014
Last Update Submitted That Met QC Criteria
November 14, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UHN
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Abdominal Aortic Aneurysm (AAA)
-
Medtronic CardiovascularCompletedAbdominal Aortic Aneurysms (AAA)United States
-
Vascutek Ltd.TerminatedAbdominal Aortic Aneurysms (AAA)United Kingdom, Netherlands, Switzerland, Spain, Germany, Belgium, Sweden, Canada, France, Italy, Austria, Monaco
-
EndologixRecruitingAAA | AAA - Abdominal Aortic AneurysmUnited States
-
EndologixNot yet recruitingAAA | AAA - Abdominal Aortic Aneurysm
-
Washington University School of MedicineRecruitingAbdominal Aortic Aneurysm (AAA) | No Abdominal Aortic Aneurysm (Non-AAA)United States
-
W.L.Gore & AssociatesNot yet recruitingAAA - Abdominal Aortic Aneurysm
-
Imperial College LondonNot yet recruiting
-
NureaWithdrawn
-
Clalit Health ServicesMedtronicCompleted
-
Medtronic CardiovascularRecruitingAAA - Abdominal Aortic AneurysmSpain, Germany, Portugal, Switzerland, Austria, France, Greece, Ireland, Italy, Netherlands, Russian Federation, Slovakia, Sweden, United Kingdom
Clinical Trials on Using pre-procedural CTA to guide advanced EVAR procedure
-
Institute of Liver and Biliary Sciences, IndiaCompleted